NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH
loading...

The Effects of Medicare Advantage on Opioid Use

Laurence C. Baker, Kate Bundorf, Daniel Kessler

NBER Working Paper No. 25327
Issued in December 2018
NBER Program(s):Health Care, Health Economics, Public Economics

Despite a vast literature on the determinants of prescription opioid use, the role of health insurance plans has received little attention. We study how the form of Medicare beneficiaries’ drug coverage affects the volume of opioids they consume. We find that enrollment in Medicare Advantage, which integrates drug coverage with other medical benefits, significantly reduces beneficiaries’ likelihood of filling an opioid prescription, as compared to enrollment in a stand-alone drug plan. Approximately half of this effect was due to fewer fills from prescribers who write a very large number of opioid prescriptions.

download in pdf format
   (278 K)

email paper

Machine-readable bibliographic record - MARC, RIS, BibTeX

Document Object Identifier (DOI): 10.3386/w25327

Published: Laurence C. Baker & M. Kate Bundorf & Daniel P. Kessler, 2019. "The Effects of Medicare Advantage on Opioid Use," Journal of Health Economics, .

 
Publications
Activities
Meetings
NBER Videos
Themes
Data
People
About

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us